{"prompt": "['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', '16.', 'REFERENCES', 'Fuenmayor LD, Vogt M. The influence of cerebral 5-hydroxytryptamine on catalepsy induced by', 'brain-amine depleting neuroleptics or by cholinomimetics. B J Pharmacol 1979;67(2):309-18.', 'Gilbert D, Jankovic J. Pharmacological treatment of Tourette syndrome. J Obsessive Compuls', 'Rel Disord 2014;3:407-14.', 'Heitjan F and Little RJA. Multiple Imputation for the Fatal Accident Reporting System. Applied', 'Statistics 1991;40:13-29.', 'Jain S, Greene PE, Frucht SJ. Tetrabenazine therapy of pediatric hyperkinetic movement', 'disorders. Mov Disord 2006;21(11):1966-72.', 'Jankovic J. Therapeutic developments for tics and myoclonus. Mov Disord', '2015;30(11): 1566-73.', 'Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin', 'Neuropharmacol 1995;18(3):197-214.', \"Jankovic J. Tourette's syndrome. N Engl J Med 2001;345(16): 1184-92.\", 'Jankovic J, Beach J. Long-term effects of tetrabenazine in hyperkinetic movement. Neurology', '1997;48(2):358-62.', 'Jankovic J, Kurlan R. Tourette syndrome: evolving concepts. Mov Disord 2011;26(6):1149.', 'Kenney C, Hunter C, N M, Jankovic J. Tetrabenazine in the treatment of Tourette syndrome. J', 'Pediatric Neurol 2007;5(1):9-13.', 'Kurlan R, Como PG, Miller B, Palumbo D, Deeley C, Andresen EM, et al. The behavioral', 'spectrum of tic disorders: a community-based study. Neurology 2002;59(3):414-20', 'Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic', 'Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc', 'Psychiatry 1989;28(4):566-73.', 'Little RJA and Rubin DB. Statistical Analysis with Missing Data, Second Edition. New York:', 'John Wiley & Sons 2002.', 'Mejia NI, Jankovic J. Tardive dyskinesia and withdrawal emergent syndrome in children. Expert', 'Rev Neurother 2010Jun;10(6):893-901', 'Mehanna R, Hunter C, Davidson A, Jimenez-Shahed J, Jankovic J. Analysis of CYP2D6', 'genotype and response to tetrabenazine. Mov Disord 2013 Feb;28(2):210-5.', 'Paleacu D, Giladi N, Moore O, Stern A, Honigman S, Badarny S. Tetrabenazine treatment in', 'movement disorders. Clin Neuropharmacol 2004;27(5):230-3.', 'Pasricha PJ, Pehlivanov N, Sugumar A, Jankovic J. Drug Insight: from disturbed motility to', 'disordered movement-a review of the clinical benefits and medicolegal risks of', 'metoclopramide. Nat Clin Pract Gastroenterol Hepatol 2006;3(3):138-48.', 'Pe\u00f1a MS, Yaltho TC, Jankovic J. Tardive dyskinesia and other movement disorders secondary to', 'aripiprazole. Mov Disord 2011 Jan;26(1):147-52.', '114']['Placebo-Controlled Study-Tourette Syndrome', 'Clinical Study Protocol with Amendment 05', 'Study TV50717-CNS-30046', \"Porta M, Sassi M, Cavallazzi M, Fornari M, Brambilla A, Servello D. Tourette's syndrome and\", 'role of tetrabenazine: review and personal experience. Clin Drug Investig 2008;28(7):443.', 'Rubin DB. Multiple Imputation for Nonresponse in Surveys, New York: John Wiley & Sons.', '1987.', \"Scahill L, Riddle MA, McSwiggin-Hardin M, Ort SI, King RA, Goodman WL, et al. Children's\", 'Yal-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc', 'Psychiatry 1997;36(6):844-52', 'Schenker N and Taylor JMG. Partially Parametric Techniques for Multiple Imputation.', 'Computational Statistics and Data Analysis 1996;22:425-446.', 'Scherman D, Gasnier B, Jaudon P, Henry JP. Hydrophobicity of the tetrabenazine-binding site of', 'the chromaffin granule monoamine transporter. Mol Pharmacol 1988;33(1):72-7.', 'Shaw Z, Coffey B. Tics and Tourette syndrome. Psychiatr Clin North Am 2014 Sep;37(3):269-', '86.', 'Su M, McFarlane F, Cavanna A, et al. The English Version of the Gilles de la Tourette', 'Syndrome-Quality of Life Scale for Children and Adolescents (C&A-GTS-QOL). J Child', 'Neurol 2017;32(1):76-83', \"Sun S, Wang S. The Children's Depression Inventory in worldwide child development research:\", 'a reliability generalization study. J Child Fam Stud 2015;24(8):2352-63.', 'Waln O, Jankovic J. An update on tardive dyskinesia: from phenomenology to treatment. Tremor', 'and other hyperkinetic movements. Tremor Other Hyperkinet Mov 2013;3', 'Wijemanne S, Wu LJ, Jankovic J. Long-term efficacy and safety of fluphenazine in patients with', 'Tourette syndrome. Mov Disord 2014 Jan;29(1):126-30', 'Xenazine: Highlights of Prescribing Information. 2015. Available at:', 'http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/021894s010lbl.pdf. Accessed 27', 'Oct 2015.', '115']\n\n###\n\n", "completion": "END"}